首页> 外国专利> APPLICATION OF PYRIMIDINE DERIVATIVES FOR TREATMENT OF EGFR-DEPENDENT DISEASES OR DISEASES WITH ACQUIRED RESISTANCE TO AGENTS AIMED AGAINST MEMBERS OF EGFR FAMILY

APPLICATION OF PYRIMIDINE DERIVATIVES FOR TREATMENT OF EGFR-DEPENDENT DISEASES OR DISEASES WITH ACQUIRED RESISTANCE TO AGENTS AIMED AGAINST MEMBERS OF EGFR FAMILY

机译:嘧啶衍生物在治疗EGFR依赖型疾病或对EGFR家族成员产生耐药性的疾病中的应用

摘要

1. The use of the compounds of formula I! ! or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein W is CRw or N, wherein Rw is selected from the group consisting of! (1) hydrogen,! (2) cyano group,! (3) halogen,! (4) methyl,! (5) trifluoromethyl,! (6) sulfonamido group,! R1 is selected from the group including! (1) hydrogen,! (2) cyano group,! (3) nitro group,! (4) halogen,! (5) substituted and unsubstituted alkyl,! (6) substituted and unsubstituted alkenyl,! (7) substituted or unsubstituted alkynyl,! (8) substituted or unsubstituted aryl,! (9) substituted or unsubstituted heteroaryl,! (10) substituted or unsubstituted heterocyclyl,! (11) substituted or unsubstituted cycloalkyl,! (12) -COR1a,! (13) -CO2R1a,! (14) -CONR1aR1b,! (15) -NR1aR1b,! (16) -NR1aCOR1b,! (17) -NR1aSO2R1b,! (18) -OCOR1a,! (19) -OR1a,! (20) -SR1a,! (21) -SOR1a,! (22) -SO2R1a and! (23) -SO2NR1aR1b,! wherein R1a and R1b are independently selected from the group consisting of! (a) hydrogen,! (b) substituted and unsubstituted alkyl,! (c) substituted and unsubstituted aryl,! (d) substituted and unsubstituted heteroaryl,! (e) substituted and unsubstituted heterocyclyl and! (e) substituted and unsubstituted cycloalkyl,! R2 is selected from the group consisting of! (1) hydrogen,! (2) cyano group,! (3) nitro group,! (4) halogen,! (5) hydroxy group,! (6) amino group,! (7) substituted and unsubstituted alkyl,! (8) -COR2a and! (9) -NR2aCOR2b,! wherein R2a and R2b are independently selected from the group consisting of! (a) hydrogen and! (b) substituted and unsubstituted alkyl,! R3 is selected from the group including! (1) hydrogen,! (2) cyano group,! (3) nitro group,! (4) halogen,! (5) substituted and unsubstituted alkyl,! (6) substituted and unsubstituted alkenyl,! (7) substituted and unsubstituted alkynyl,! (8) substituted and unsubstituted aryl,! (9) substituted and unsubstituted heteroaryl,! (10) is substituted�
机译:1.式I化合物的用途! !或其立体异构体,互变异构体或其药学上可接受的盐,其中W为CRw或N,其中Rw选自下组: (1)氢! (2)氰基! (3)卤素! (4)甲基! (5)三氟甲基! (6)磺酰胺基!从包括以下在内的组中选择R1! (1)氢! (2)氰基! (3)硝基,! (4)卤素! (5)取代和未取代的烷基,! (6)取代和未取代的烯基,! (7)取代或未取代的炔基,! (8)取代或未取代的芳基,! (9)取代或未取代的杂芳基,! (10)取代或未取代的杂环基,! (11)取代或未取代的环烷基,! (12)-COR1a! (13)-CO2R1a! (14)-CONR1aR1b ,! (15)-NR1aR1b ,! (16)-NR1aCOR1b ,! (17)-NR1aSO2R1b ,! (18)-OCOR1a ,! (19)-OR1a! (20)-SR1a! (21)-SOR1a! (22)-SO2R1a和! (23)-SO2NR1aR1b ,!其中R1a和R1b独立地选自: (一)氢! (b)取代和未取代的烷基,! (c)取代和未取代的芳基,! (d)取代和未取代的杂芳基,! (e)取代和未取代的杂环基和! (e)取代和未取代的环烷基,! R2选自: (1)氢! (2)氰基! (3)硝基,! (4)卤素! (5)羟基! (6)氨基! (7)取代和未取代的烷基,! (8)-COR2a和! (9)-NR2aCOR2b ,!其中R2a和R2b独立地选自: (一)氢和! (b)取代和未取代的烷基,!从包括以下在内的组中选择R3! (1)氢! (2)氰基! (3)硝基,! (4)卤素! (5)取代和未取代的烷基,! (6)取代和未取代的烯基,! (7)取代和未取代的炔基,! (8)取代和未取代的芳基,! (9)取代和未取代的杂芳基,! (10)被替换。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号